Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/17/21 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
14 | |
| 05/17/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
37 |
| 05/14/21 | 8-K | Current report filing |
|
2 | |
| 05/03/21 | 8-K/A | Current report filing |
|
2 | |
| 05/03/21 | 8-K | Current report filing |
|
2 | |
| 04/01/21 | 8-K | Current report filing |
|
2 | |
| 04/01/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/01/21 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 03/30/21 | 8-K | Current report filing |
|
3 | |
| 03/10/21 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
3 |
